Mnemo Therapeutics is a Paris-based biotechnology company driven to create powerful immunotherapies by improving the body’s ability to detect and eradicate cancer. The paucity of actionable cancer-specific targets creates significant challenges in the field of immuno-oncology. To address this, Mnemo has developed a combination of in-silico and wet-lab pipelines to uncover new tumour-specific targets (called E-antigens) derived from the unexploited dark genome, and to develop multiple therapeutic modalities (i.e. cell therapy, TCE, ADC, vaccine) targeting these E-antigens. Mnemo is currently pursuing several discovery campaigns for E-antigens, with a plan to develop its proprietary tumour-specific targets and therapeutics portfolio together with its historic founding partners.
Company Details
- Employees
- 24
- Founded
- -
- Address
- 101 Boulevard Murat, Paris,île-De-France 75016,france
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.mnemo-tx.com/
- Keywords
- Sales Representative jobs.
- HQ
- Paris, Île-de-France
Mnemo Therapeutics Questions
Mnemo Therapeutics's website is https://www.mnemo-tx.com/
Mnemo Therapeutics's LinkedIn profile is https://fr.linkedin.com/company/mnemo-therapeutics
Mnemo Therapeutics has
24 employees.
View email and phone details for 24
employees at Mnemo Therapeutics.
Mnemo Therapeutics's industry is
Biotechnology Research
Mnemo Therapeutics's top competitors are
Owkin,
Sparingvision,
Treefrog Therapeutics,
Cellectis,
Aqemia,
Coave Therapeutics,
Bioptimus,
Enterome,
Imcheck Therapeutics,
Brenus Pharma.
Mnemo Therapeutics's categories are Biotechnology Research
Mnemo Therapeutics's founding year is 2019
